These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18019542)

  • 1. Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinase.
    Barbeau OR; Cano-Soumillac C; Griffin RJ; Hardcastle IR; Smith GC; Richardson C; Clegg W; Harrington RW; Golding BT
    Org Biomol Chem; 2007 Aug; 5(16):2670-7. PubMed ID: 18019542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
    Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
    J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Judicious application of allyl protecting groups for the synthesis of 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl triflate, a key precursor of DNA-dependent protein kinase inhibitors.
    Aristegui SR; El-Murr MD; Golding BT; Griffin RJ; Hardcastle IR
    Org Lett; 2006 Dec; 8(26):5927-9. PubMed ID: 17165896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).
    Hollick JJ; Golding BT; Hardcastle IR; Martin N; Richardson C; Rigoreau LJ; Smith GC; Griffin RJ
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3083-6. PubMed ID: 12941339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
    O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
    Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
    Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
    Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile diversity-oriented synthesis and antitubercular evaluation of novel aryl and heteroaryl tethered pyridines and dihydro-6H-quinolin-5-ones derived via variants of the Bohlmann-Rahtz Reaction.
    Kantevari S; Patpi SR; Addla D; Putapatri SR; Sridhar B; Yogeeswari P; Sriram D
    ACS Comb Sci; 2011 Jul; 13(4):427-35. PubMed ID: 21699150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Versatile synthesis of functionalised dibenzothiophenes via Suzuki coupling and microwave-assisted ring closure.
    Rodriguez-Aristegui S; Clapham KM; Barrett L; Cano C; Desage-El Murr M; Griffin RJ; Hardcastle IR; Payne SL; Rennison T; Richardson C; Golding BT
    Org Biomol Chem; 2011 Sep; 9(17):6066-74. PubMed ID: 21748189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suzuki-Miyaura cross-coupling reactions of halo derivatives of 4H-pyrido[1,2-a]pyrimidin-4-ones.
    Molnár A; Kapros A; Párkányi L; Mucsi Z; Vlád G; Hermecz I
    Org Biomol Chem; 2011 Oct; 9(19):6559-65. PubMed ID: 21808806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities.
    Hafez HN; El-Gazzar AR; Zaki ME
    Acta Pharm; 2016 Sep; 66(3):331-51. PubMed ID: 27383884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
    Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
    J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.
    Morrison R; Al-Rawi JM
    J Enzyme Inhib Med Chem; 2016; 31(sup2):86-95. PubMed ID: 27255290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-substituted-5-halo-2,3-dihydro-4(H)-pyrimidin-4-ones and their derivatization utilizing the Sonogashira coupling reaction in the enantioselective synthesis of alpha-substituted beta-amino acids.
    Díaz-Sánchez BR; Iglesias-Arteaga MA; Melgar-Fernández R; Juaristi E
    J Org Chem; 2007 Jun; 72(13):4822-5. PubMed ID: 17523668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.
    Leahy JJ; Golding BT; Griffin RJ; Hardcastle IR; Richardson C; Rigoreau L; Smith GC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6083-7. PubMed ID: 15546735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise synthesis of rare pyrido[1,2-a]pyrimidin-2-ones and related nitrogen-rich bicyclic scaffolds with a ring-junction nitrogen.
    Alanine TA; Galloway WR; Bartlett S; Ciardiello JJ; McGuire TM; Spring DR
    Org Biomol Chem; 2016 Jan; 14(3):1031-8. PubMed ID: 26632452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some novel pyrido[1,2-a]pyrimidin-4-ones as antimalarial agents.
    Mane UR; Mohanakrishnan D; Sahal D; Murumkar PR; Giridhar R; Yadav MR
    Eur J Med Chem; 2014 May; 79():422-35. PubMed ID: 24763263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-ones.
    Rajput S; Gardner CR; Failes TW; Arndt GM; Black DS; Kumar N
    Bioorg Med Chem; 2014 Jan; 22(1):105-15. PubMed ID: 24332654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton.
    Jantová S; Urbancíková M; Maliar T; Mikulásová M; Rauko P; Cipák L; Kubíková J; Stankovský S; Spirková K
    Neoplasma; 2001; 48(1):52-60. PubMed ID: 11327538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
    Suhagia BN; Chhabria MT; Makwana AG
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.
    Han SY; Choi JW; Yang J; Chae CH; Lee J; Jung H; Lee K; Ha JD; Kim HR; Cho SY
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2837-42. PubMed ID: 22450128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.